Clinical study of blocompatibility between open and closed heparin-coated cardiopulmonary bypass circuits

Journal of Artificial Organs

Volumn 6, Issue 4, 2003, Pages 245-252

  Tanaka, Hiroyuki ^a   Oshiyama, Takanori ^a   Narisawa, Takashi ^a   Mori, Takanobu ^a   Masuda, Mikio ^a   Kishi, Daijirou ^a   Kitou, Takashi ^a   Miyazima, Shingo ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Cardiopulmonary bypass; Closed circuit; Heparin coated; Open circuit

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; D DIMER; FIBRINOGEN; HEMOGLOBIN; HEPARIN; INTERLEUKIN 6; LEUKOCYTE ELASTASE; PLASMIN; PROTAMINE; THROMBIN ANTITHROMBIN COMPLEX; BIOMATERIAL;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CENTRIFUGE; CLINICAL ARTICLE; CLOSED CIRCUIT CARDIOPULMONARY BYPASS; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HEART VALVE SURGERY; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MALE; MEDICAL INSTRUMENTATION; OPEN CIRCUIT CARDIOPULMONARY BYPASS; PRIORITY JOURNAL; RANDOMIZATION; SUCTION; THROMBOCYTE COUNT; BLOOD ANALYSIS; BLOOD CLOTTING TEST; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; EQUIPMENT; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; FOLLOW UP; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

AGED; BLOOD CHEMICAL ANALYSIS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CARDIOPULMONARY BYPASS; COATED MATERIALS, BIOCOMPATIBLE; EQUIPMENT DESIGN; EQUIPMENT SAFETY; EXTRACORPOREAL CIRCULATION; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0348049641     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-003-0237-5     Document Type: Article

References (22)

1. Borowiec JW, Bylock A, van der Linden J, Thelin S. Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: A clinical study. Ann Thorac Surg 1993;55:1540-1545
2. Hattori K. Clinical effects of standard and heparin-coated circuit on coagulation and fibrinolysis during cardiopulmonary bypass. Jpn J Artif Organs 1996;25:649-654
3. Takeda F, Inui K, Watanabe T, Kuraoka S, Iizima Y, Minowa T, Miura M, Uchino H, Shimazaki Y. Systemic inflammatory response using heparin-coated cardiopulmonary bypass circuits-A comparison with non-coated equipments. Jpn J Artif Organs 1998;27:413-417
4. Moen O, Fosse E, Braten J, Andersson C, Fagerhol MK, Venge P, Hogasen K, Mollnes TE. Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and complement activation. Perfusion 1994;9:109-117
5. Schonberger J, Everts P, Hoffmann J. Systemic blood activation with open and closed venous reservoirs. Ann Thorac Surg 1995;59:1549-1555
6. Nishida H, Aomi S, Tomizawa Y, Endo M, Koyanagi H, Nojiri C, Oshiyama H, Kido T, Tokoyama K. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass. Artif Organs 1999;23:547-551
7. Wildevuur CRH. Blood interaction in extracorporeal circulation: tests to evaluate the activation of proteins and formed blood elements. Life Support Syst 1987;5:85-88
8. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845-857
9. Aldea GS, O'Gara P, Shapira OM, Treanor P, Osman A, Patalis E, Arkin C, Diamond R, Babikian V, Lazar HL, Shemin RJ. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. Ann Thorac Surg 1998;65:425-433
10. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981;304:497-503
11. Holloway DS, Summaria L, Sandesara J, Vagher JP, Alexander JC, Caprini JA. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 1988;59:62-67
12. Kusserow B, Larrow R, Nicholls J. Perfusion- and surface-induced injury in leucocytes. Fed Proc 1971;30:1516-1520
13. Kim WG, Na MH, Kim JH. Is avoidance of air contact necessary for the in vitro evaluation of thrombogenicity in mechanical circulatory assist devices? Artif Organs 2000;24:729-733
14. McCarthy PM, Yared JP, Foster RC, Ogella DA, Borsh JA, Cosgrove DM. A prospective randomized trial of Duraflo Il heparin-coated circuits in cardiac reoperations. Ann Thorac Surg 1999;67:1268-1273
15. Jensen E, Andreasson S, Bengtsson A, Berggren H, Ekroth R, Lindholm L, Ouchterlony J. Influence of two different perfusion systems on inflammatory response in pediatric heart surgery. Ann Thorac Surg 2003;75:919-925
16. Tabuchi N, de Haan J, Boonsta PW, van Oeveren W. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106:828-833
17. Wildevuur CRH. Blood damage and activation in cardiopulmonary bypass. In: Friedel N, Hertzer R, Royston D (eds) Blood use in cardiac surgery. New York: Springer, 1991;269-274
18. Bengtson JP, Backman L, Stenqvist O, Heideman M, Bengtsson A. Complement activation and reinfusion of wound drainage blood. Anaesthesiology 1990;73:376-380
19. Hsu L. Biocompatibility in cardiopulmonary bypass. J Cardiothorac Vasc Anesthesiol 1997;11:376-382
20. Khuri SF, Valeri CR, Loscalzo J, Weinstein MJ, Birjiniuk V, Healey NA, MacGregor H, Doursounian M, Zolkewitz MA. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg 1995;60:1008-1014
21. von Segesser LK, Wiess BM, Garcia E, Gallino A, Turina M. Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization. Eur J Cardiothorac Surg 1990;4:639-643
22. Bull BS, Huse WM, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individdualize heparin and protamin dosage. J Thorac Cardiovasc Surg 1975;69:685-689